Drug Pipeline

ONC206 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07282587 Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma Advanced Pheochromocytoma and Paraganglioma Recruiting
NCT07533942 A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Meningioma Not Yet Recruiting
Phase 1
NCT04732065 ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other… Diffuse Midline Glioma (DMG) Recruiting
Sponsors Running ONC206 Trials
Jazz Pharmaceuticals (2) Sabine Mueller, MD, PhD (1)
Disease Areas
Glioma (2) Glioblastoma (1)
Get alerts when ONC206 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free